Quintet Private Bank (Europe) S.A. Moderna, Inc. Transaction History
Quintet Private Bank (Europe) S.A.
- $1.82 Trillion
- Q4 2024
A detailed history of Quintet Private Bank (Europe) S.A. transactions in Moderna, Inc. stock. As of the latest transaction made, Quintet Private Bank (Europe) S.A. holds 50 shares of MRNA stock, worth $1,630. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 55
9.09%
Holding current value
$1,630
Previous $3.68 Million
43.44%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MRNA
# of Institutions
909Shares Held
235MCall Options Held
10.6MPut Options Held
18.6M-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.31 Billion0.05% of portfolio
-
Baillie Gifford & CO38.9MShares$1.27 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$833 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$549 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$236 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...